home / stock / lixt / lixt news


LIXT News and Press, Lixte Biotechnology Holdings Inc. From 08/25/25

Stock Information

Company Name: Lixte Biotechnology Holdings Inc.
Stock Symbol: LIXT
Market: NASDAQ
Website: lixte.com

Menu

LIXT LIXT Quote LIXT Short LIXT News LIXT Articles LIXT Message Board
Get LIXT Alerts

News, Short Squeeze, Breakout and More Instantly...

LIXT - Morning Market Pulse: Biotech Rises, Crypto Converges, and M&A Builds Momentum

2025-08-25 09:32:18 ET DENVER, Colo., Aug 25, 2025 ( 247marketnews.com )- Biotech buzz and digital asset disruption are driving early gains across key small-cap tickers, as investors digest earnings, clinical milestones, and bold strategic moves from firms like HCW Biologics (NASDAQ:HCW...

LIXT - LIXTE Targets Large, Unmet Oncology Markets

2025-08-25 08:06:38 ET Current Clinical Trial Focus is MSS Colorectal Cancer, Ovarian Clear-Cell Carcinoma, and Soft-Tissue Sarcoma DENVER, Colo., Aug 25, 2025- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and corpor...

LIXT - 24/7 Market News: LIXTE Targets Large, Unmet Oncology Markets

DENVER, Aug. 25, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on d...

LIXT - Biotech & Solar Blaze Into the Close: After-Hours Watchlist Heats Up

2025-08-15 14:53:09 ET DENVER, Colo., Aug 15, 2025 ( 247marketnews.com )- As we approach the final stretch of Tuesday’s trading session, momentum is building across the biotech/biopharma and solar/energy sectors, with several names lining up for potential after-hours fire...

LIXT - Quarterly Surge and FDA Milestones

2025-08-15 10:24:13 ET DENVER, Colo., Aug 15, 2025 ( 247marketnews.com )- Wall Street kicked off another jam-packed day of earnings reports, biotech breakthroughs, and strategic momentum that could set the tone for the back half of the year. VENU’s (NYSE:VENU) second-quar...

LIXT - 24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025

Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued Press Release with same title DENVER, Aug. 14, 2025 (GLOBE NE...

LIXT - Charging Into After-Hours: Small-Caps Close Strong as XPON, VENU, and LIXT Light Up the Board

2025-08-14 15:54:11 ET DENVER, Colo., Aug 14, 2025 ( 247marketnews.com )-  Markets are heading into the close of today’s session with a jolt of small-cap strength and a flurry of after-hours anticipation as several emerging growth names closed near highs. Leading the cha...

LIXT - Underdogs Unleashed: XPON, VENU, LIXT Power Through Resistance with Real Results

2025-08-14 10:10:08 ET DENVER, Colo., Aug 14, 2025 ( 247marketnews.com )- Markets are waking up to a flurry of action in the small and mid-cap space as Thursday morning kicks off with pre-market surges, biotech momentum, and institutional tailwinds in entertainment infrastructure. ...

LIXT - 24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025

DENVER, Aug. 14, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, spotlights LIXTE Biotechnology Holdings (Nasdaq: LIXT), a clinical-stage pharmaceutical company focused on devel...

LIXT - Afternoon Watchlist Builds as Busy Biotech, Blockbuster IPs & Big Institutional Bets Power Late-Day Surge

2025-08-13 14:33:21 ET DENVER, Colo., Aug 13, 2025 ( 247marketnews.com )- Markets are pulsing with momentum heading into the final stretch of the trading day, with several names setting up for extended-session fireworks. Shares of Momentus (NASDAQ:MNTS) , today’s most act...

Previous 10 Next 10